How to camouflage a factory of 53,000 workers

"If I Had To Pour Every Single Penny of My Retirement Into Just ONE STOCK..." The former Goldman Sachs VP – who called everything from Microsoft's 1,100% surge... to the death of the 60/40 portfolio – is now stepping forward with his most explicit message yet: "Make this ONE STOCK the cornerstone of your portfolio."

Assaf Wand Biography and Net Worth

Insider of Hippo

Assaf Wand is a co-founder of Hippo and has served as a member of our board of directors and our Chief Executive Officer since October 2015. Prior to Hippo, Mr. Wand was the founder and Chief Executive Officer of Sabi Inc., a consumer goods company, from May 2009 to October 2015. Mr. Wand also served as a consultant with McKinsey & Company from August 2005 to December 2006. Mr. Wand holds an MBA from the University of Chicago Booth School of Business and a dual degree from the Interdisciplinary Center Herzliya in Israel for a B.A. in finance and an LL.B in law.

How old is Assaf Wand?: Mr. Wand is currently 49 years old. There are 6 older executives and no younger executives at Hippo. The oldest executive at Hippo is Mr. Timothy Arthur Bienek CFA, Chief Insurance Strategy Officer, who is 65 years old. Learn More on Assaf Wand's age.
How do I contact Assaf Wand?: The corporate mailing address for Mr. Wand and other Hippo executives is 215 PARK AVENUE FLOOR 11, NEW YORK NY, 10003. Hippo can also be reached via phone at 650-294-8463 and via email at [email protected]. Learn More on Assaf Wand's contact information.
Has Assaf Wand been buying or selling shares of Hippo?: Assaf Wand has not been actively trading shares of Hippo within the last three months. Most recently, on Friday, November 19th, Assaf Wand bought 40,650 shares of Hippo stock. The stock was acquired at an average cost of $3.70 per share, with a total value of $150,405.00. Learn More on Assaf Wand's trading history.
Who are Hippo's active insiders?: Hippo's insider roster includes Stewart Ellis (CFO & Treasurer ), Ran Harpaz (COO & CTO ), Sam Landman (Director), Richard McCathron (President), and Assaf Wand (Insider). Learn More on Hippo's active insiders.
Are insiders buying or selling shares of Hippo?: In the last twelve months, Hippo insiders bought shares 3 times. They purchased a total of 35,069 shares worth more than $373,308.73. In the last twelve months, insiders at the sold shares 2 times. They sold a total of 16,673 shares worth more than $288,840.25. The most recent insider tranaction occured on March, 22nd when CRO Yuval Harry sold 14,938 shares worth more than $256,933.60. Insiders at Hippo own 11.3% of the company. Learn More about insider trades at Hippo.
Information on this page was last updated on 3/22/2024.

Assaf Wand Insider Trading History at Hippo

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
11/19/2021	Buy	40,650	$3.70	$150,405.00

Assaf Wand Buying and Selling Activity at Hippo

Hippo Company Overview

Hippo Holdings Inc. provides property and casualty insurance products to individuals and business customers primarily in the United States. The company operates through three segments: Services, Insurance-as-a-Service, and Hippo Home Insurance Program. Its insurance products include homeowners' insurance against risks of fire, wind, and theft, as well as other personal lines policies from third party carriers; and personal and commercial, as well as home, auto, cyber, small business, life, specialty lines, and other insurance products. The company distributes insurance products and services through its technology platform and website, as well as operates licensed insurance agencies. Hippo Holdings Inc. is headquartered in Palo Alto, California.

Today's Range

Now: $20.97

$20.81

$21.48

50 Day Range

MA: $17.55

$10.60

$24.40

2 Week Range

Now: $20.97

$6.64

$25.49

Volume

15,870 shs

Average Volume

169,130 shs

Market Capitalization

$509.78 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.57

How to camouflage a factory of 53,000 workers

From Stansberry Research | Ad

Get the full story here.